CA Patent

CA3132832A1 — Antiviral prodrugs and formulations thereof

Assigned to University of Nebraska System · Expires 2019-10-17 · 7y expired

What this patent protects

The present invention provides prodrugs and methods of use thereof.

USPTO Abstract

The present invention provides prodrugs and methods of use thereof.

Drugs covered by this patent

cabotegravir-sodium (CABOTEGRAVIR SODIUM)

Patent Metadata

Patent number: CA3132832A1
Jurisdiction: CA
Classification: —
Expires: 2019-10-17
Drug substance claim: No
Drug product claim: No
Assignee: University of Nebraska System
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.